시장보고서
상품코드
1838788

반려동물 백신 시장 분석 및 예측(-2034년) : 유형, 제품, 기술, 용도, 최종사용자, 기능, 서비스, 전개, 재료 유형, 단계

Companion Animal Vaccines Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Functionality, Services, Deployment, Material Type, Stage

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 447 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

반려동물 백신 시장은 2024년 42억 2, 000만 달러에서 2034년 약 97억 9, 000만 달러에 이르고, 약 8.8%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 반려동물 백신 시장은 광견병, 디스템퍼, 고양이 백혈병 등의 질병을 예방하기 위한 개, 고양이 등 반려동물 백신의 개발 및 유통을 포괄합니다. 이 시장을 주도하는 것은 반려동물 사육 수 증가, 동물 건강에 대한 인식 증가, 생명공학 기술의 발전입니다. 백신의 효능과 안전성을 높이는 데 중점을 두고 있으며, 재조합 백신과 DNA 백신의 기술 혁신이 그 견인차 역할을 하고 있습니다. 전 세계적으로 수의학 수준이 향상됨에 따라 종합적인 예방접종 프로그램에 대한 수요는 지속적으로 증가하고 있으며, 이 분야에서 큰 성장 기회가 나타나고 있습니다.

반려동물 백신 시장은 반려동물 양육률 증가와 동물 건강에 대한 인식이 높아짐에 따라 강력한 성장세를 보이고 있습니다. 광견병 백신과 디스템퍼 백신은 규제 요건과 널리 보급되어 있기 때문에 특히 필수적입니다. 고양이 백신은 고양이 특유의 질병에 대한 인식이 높아지면서 고양이 백혈병 백신과 광견병 백신이 견인차 역할을 하고 있습니다. 반려동물용 가축 백신도 반려동물을 반려동물로 키우려는 경향이 높아지면서 중요한 하위 부문으로 부상하고 있습니다. 여러 질병에 대한 종합적인 방어와 편의성을 제공하는 혼합백신에 대한 수요가 증가하고 있습니다. 주사용 백신은 그 효과와 투여의 용이성으로 인해 시장을 독점하고 있습니다. 그러나 비침습적 적용과 빠른 면역 반응으로 인해 비강 백신의 인기가 높아지고 있습니다. 재조합 DNA 기술 등 백신 개발의 기술 발전은 백신의 효능과 안전성을 높이고 시장 확대의 기회를 제공합니다. 예방적 헬스케어에 대한 트렌드가 시장 성장을 더욱 촉진하고 있습니다.

시장 세분화
유형 생백신, 불활화 백신, 유전자 재조합 백신, 톡소이드 백신, 혼합 백신, 아단위 백신, DNA 백신
제품 개용 백신, 고양이용 백신, 말용 백신
기술 재조합 DNA 기술, 세포배양 기술
용도 광견병, 디스템퍼, 파보바이러스, 렙토스피라증, 고양이 백혈병, 말 인플루엔자
최종사용자 동물 클리닉, 동물 병원, 연구기관
기능 예방 백신, 치료용 백신
서비스 백신 접종 서비스, 상담 서비스
전개 On-Premise, 클라우드 기반
재료 유형 바이오, 합성
단계 전임상, 임상시험, 상업화

시장 현황

반려동물 백신 시장은 소비자의 선호도 변화와 반려동물의 건강에 대한 인식이 높아지면서 역동적으로 성장하고 있습니다. 시장 점유율은 주로 기존 제약사들이 차지하고 있지만, 혁신적 제품 출시를 통해 스타트업들이 크게 진출하고 있습니다. 가격 경쟁은 여전히 계속되고 있으며, 각 업체는 저렴한 가격과 고급 백신 제제의 필요성과 균형을 맞추기 위해 노력하고 있습니다. 신제품 출시가 빈번하게 이루어지고 있으며, 이는 다양한 수의학적 요구에 대응하기 위한 지속적인 연구 개발 노력을 반영하고 있습니다. 시장은 예방의학에 중점을 두고 있으며, 이것이 수요를 지속적으로 견인하고 있습니다. 반려동물 백신 시장의 경쟁은 치열하며, 주요 기업들은 경쟁력을 유지하기 위해 기술 발전을 활용하고 있습니다. 벤치마크에 따르면, 최첨단 연구와 탄탄한 유통망에 투자하는 기업이 특히 성공적이라고 합니다. 규제의 영향은 중요한 역할을 하고 있으며, 북미와 유럽의 엄격한 가이드라인이 시장 역학을 형성하고 있습니다. 이러한 규제는 높은 수준을 보장하고, 소비자의 신뢰를 형성합니다. 시장 분석에 따르면, 규제적 과제는 여전히 존재하지만, 차별화와 혁신의 기회이기도 합니다. 반려동물을 키우는 인구 증가와 동물 건강에 대한 인식이 높아짐에 따라 수요가 증가하고 있으며, 시장은 성장할 태세를 갖추고 있습니다.

주요 트렌드와 촉진요인:

반려동물 백신 시장은 반려동물 사육 증가와 동물 건강에 대한 인식이 높아짐에 따라 강력한 성장세를 보이고 있습니다. 중요한 추세는 더 광범위한 보호와 더 적은 부작용을 제공하는 고급 백신에 대한 수요 증가입니다. 이는 반려동물의 건강에 대해 더 많은 정보를 갖고 적극적으로 행동하는 보호자들에 의해 이루어지고 있습니다. 바이오테크놀러지의 기술적 발전은 새로운 백신의 개발을 촉진하고 효능과 안전성을 높이고 있습니다. 이러한 기술 혁신은 새로운 질병에 대응하고 진화하는 병원체에 적응하는 데 매우 중요합니다. 또한, 개별 동물의 특정 요구에 맞게 백신을 조정하고 건강상의 결과를 최적화하는 개인 맞춤형 동물 의료의 트렌드가 점점 더 힘을 얻고 있습니다. 또한, 규제 환경은 새로운 백신의 신속한 승인 절차를 지원하고 시장 출시 시간을 단축할 수 있도록 진화하고 있습니다. 인수공통전염병에 대한 전 세계적인 우려가 높아지고 잠재적 발병에 대한 민첩한 대응이 요구되는 가운데, 이는 특히 적절합니다. 반려동물 사육률이 증가하고 수의학적 인프라가 확대되고 있는 신흥 시장에는 비즈니스 기회가 넘쳐나고 있습니다. 다양한 규제 환경에 대응하고 비용 효율적인 솔루션을 제공할 수 있는 기업은 큰 시장 점유율을 확보할 준비가 되어 있습니다. 예방 의료와 장기적인 건강 혜택에 중점을 두어 반려동물 백신에 대한 지속적인 수요를 확보할 수 있습니다.

억제요인과 과제:

반려동물 백신 시장은 현재 몇 가지 중요한 시장 성장 억제요인과 문제에 직면해 있습니다. 백신 개발 및 생산과 관련된 높은 비용으로 인해 소규모 동물병원과 반려동물 보호자의 접근성을 제한하고 있는 것이 가장 큰 문제입니다. 또한, 규제적 장애물도 큰 장벽으로 작용하고 있으며, 신규 백신의 승인 절차에 많은 시간과 비용이 소요되어 시장 진입을 지연시키고 있습니다. 또한, 반려동물 보호자들 사이에서는 백신의 안전성과 효과에 대한 잘못된 정보와 회의적인 시각으로 인해 백신 접종을 주저하는 사례가 늘고 있습니다. 이로 인해 백신 접종률이 낮아져 질병 발생에 대한 취약성이 높아질 수 있습니다. 또한, 백신의 보관 기간과 보관 요건이 제한적이기 때문에 유통 물류가 복잡해지고 비용이 상승하는 제약이 있습니다. 마지막으로, 새롭게 진화하는 병원균의 출현은 지속적인 연구 개발이 필요하고, 자원을 고갈시키고, 제조업체가 역동적인 상황에 대응하는 것을 어렵게 만들고 있습니다. 이러한 문제들은 반려동물 백신 시장의 성장과 확장을 가로막는 요인으로 작용하고 있습니다.

주요 기업

Boehringer Ingelheim Animal Health, Elanco Animal Health, Virbac, Ceva Sante Animale, Vetoquinol, Heska Corporation, IDEXX Laboratories, Zoetis, Phibro Animal Health, Neogen Corporation, Biogenesis Bago, Hipra, Bioveta, Merial, MSD Animal Health, Bimeda, Aratana Therapeutics, Dechra Pharmaceuticals, Kyoritsu Seiyaku, Merial Animal Health, Arcaplanet S.p.A.가 Merial Italia S.p.A.를 인수했기 때문에 찾고 계신 주요 기업 웹사이트가 변경되었습니다. Merial Italia S.p.A.를 인수한 회사에 대한 정보는 다음을 방문하여 확인하실 수 있습니다:

목차

제1장 반려동물 백신 시장 개요

  • 조사 목적
  • 반려동물 백신 시장 정의와 조사 범위
  • 보고서 제한 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 프리미엄 인사이트

제4장 반려동물 백신 시장 전망

  • 반려동물 백신 시장 세분화
  • 시장 역학
  • Porter의 Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 반려동물 백신 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 반려동물 백신 시장 규모

  • 반려동물 백신 시장 규모 : 금액별
  • 반려동물 백신 시장 규모 : 수량별

제7장 반려동물 백신 시장 : 유형별

  • 시장 개요
  • 생백신
  • 불활화 백신
  • 재조합 백신
  • 톡소이드 백신
  • 결합 백신
  • 아단위 백신
  • DNA 백신
  • 기타

제8장 반려동물 백신 시장 : 제품별

  • 시장 개요
  • 개용 백신
  • 고양이용 백신
  • 말용 백신
  • 기타

제9장 반려동물 백신 시장 : 기술별

  • 시장 개요
  • 재조합 DNA 기술
  • 세포배양 기술
  • 기타

제10장 반려동물 백신 시장 : 용도별

  • 시장 개요
  • 광견병
  • 디스템퍼
  • 파보바이러스
  • 렙토스피라증
  • 고양이 백혈병
  • 말 인플루엔자
  • 기타

제11장 반려동물 백신 시장 : 최종사용자별

  • 시장 개요
  • 동물 클리닉
  • 동물 병원
  • 연구기관
  • 기타

제12장 반려동물 백신 시장 : 기능별

  • 시장 개요
  • 예방 백신
  • 치료용 백신
  • 기타

제13장 반려동물 백신 시장 : 서비스별

  • 시장 개요
  • 백신 접종 서비스
  • 상담 서비스
  • 기타

제14장 반려동물 백신 시장 : 전개 형태별

  • 시장 개요
  • On-Premise
  • 클라우드 기반
  • 기타

제15장 반려동물 백신 시장 : 재료 유형별

  • 시장 개요
  • 생물학적 제제
  • 합성 백신
  • 기타

제16장 반려동물 백신 시장 : 단계별

  • 시장 개요
  • 전임상시험
  • 임상시험
  • 상업화
  • 기타

제17장 반려동물 백신 시장, 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카공화국
    • 기타 중동 및 아프리카

제18장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제19장 기업 개요

  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Virbac
  • Ceva Sante Animale
  • Vetoquinol
  • Heska Corporation
  • IDEXX Laboratories
  • Zoetis
  • Phibro Animal Health
  • Neogen Corporation
  • Biogenesis Bago
  • Hipra
  • Bioveta
  • Merial
  • MSD Animal Health
  • Bimeda
  • Aratana Therapeutics
  • Dechra Pharmaceuticals
  • Kyoritsu Seiyaku
  • Merial Animal Health
LSH

Companion Animal Vaccines Market is anticipated to expand from $4.22 billion in 2024 to $9.79 billion by 2034, growing at a CAGR of approximately 8.8%. The Companion Animal Vaccines Market encompasses the development and distribution of vaccines for pets, primarily dogs and cats, aimed at preventing diseases such as rabies, distemper, and feline leukemia. This market is driven by increasing pet ownership, rising awareness of animal health, and advancements in biotechnology. The focus is on enhancing vaccine efficacy and safety, with innovations in recombinant and DNA vaccines gaining traction. As veterinary care standards rise globally, the demand for comprehensive immunization programs continues to expand, highlighting significant growth opportunities within this sector.

The Companion Animal Vaccines Market is experiencing robust growth, fueled by rising pet ownership and increased awareness of animal health. The canine vaccines segment leads performance, with rabies and distemper vaccines being particularly essential due to regulatory requirements and widespread prevalence. Feline vaccines follow closely, with feline leukemia and rabies vaccines gaining traction as awareness of feline-specific diseases rises. Livestock vaccines for companion animals are also emerging as a significant sub-segment, driven by the increasing trend of keeping livestock as pets. The demand for combination vaccines is growing, offering convenience and comprehensive protection against multiple diseases. Injectable vaccines dominate the market, favored for their efficacy and ease of administration. However, intranasal vaccines are gaining popularity for their non-invasive application and rapid immune response. Technological advancements in vaccine development, such as recombinant DNA technology, are enhancing vaccine efficacy and safety, presenting lucrative opportunities for market expansion. The trend towards preventive healthcare is further propelling market growth.

Market Segmentation
TypeLive Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Conjugate Vaccines, Subunit Vaccines, DNA Vaccines
ProductCanine Vaccines, Feline Vaccines, Equine Vaccines
TechnologyRecombinant DNA Technology, Cell Culture Technology
ApplicationRabies, Distemper, Parvovirus, Leptospirosis, Feline Leukemia, Equine Influenza
End UserVeterinary Clinics, Animal Hospitals, Research Institutes
FunctionalityProphylactic Vaccines, Therapeutic Vaccines
ServicesVaccination Services, Consultation Services
DeploymentOn-premise, Cloud-based
Material TypeBiologicals, Synthetic
StagePreclinical, Clinical Trials, Commercialized

Market Snapshot:

The Companion Animal Vaccines Market is experiencing dynamic growth, driven by evolving consumer preferences and an increasing awareness of pet health. Market share is predominantly held by established pharmaceutical companies, with emerging players making significant inroads through innovative product launches. Pricing strategies remain competitive, as companies strive to balance affordability with the need for advanced vaccine formulations. New product introductions are frequent, reflecting ongoing research and development efforts aimed at addressing diverse veterinary needs. The market is characterized by a focus on preventive care, which continues to drive demand. Competition in the Companion Animal Vaccines Market is fierce, with major firms leveraging technological advancements to maintain their competitive edge. Benchmarking reveals that companies investing in cutting-edge research and robust distribution networks are particularly successful. Regulatory influences play a critical role, with stringent guidelines in North America and Europe shaping market dynamics. These regulations ensure high standards, fostering trust among consumers. Market analysis indicates that while regulatory challenges persist, they also present opportunities for differentiation and innovation. The market is poised for growth, with increasing pet ownership and rising awareness of animal health fueling demand.

Geographical Overview:

The companion animal vaccines market is witnessing substantial growth across diverse regions, each exhibiting unique growth dynamics. North America leads the market, driven by high pet ownership rates and a strong emphasis on animal health. Increasing adoption of innovative vaccines and government initiatives supporting animal welfare further bolster this region's market position. Europe closely follows, characterized by robust veterinary healthcare infrastructure and a growing awareness of preventive healthcare for pets. Stringent regulatory frameworks also contribute to the demand for high-quality vaccines. In the Asia Pacific, the market is expanding rapidly, propelled by rising disposable incomes and a growing pet population. Countries like China and India are emerging as lucrative markets, with increased investments in veterinary healthcare. Latin America and the Middle East & Africa are also gaining traction. In Latin America, the growing trend of pet humanization is driving the demand for vaccines. Meanwhile, the Middle East & Africa are recognizing the importance of companion animal health, leading to increased investments in veterinary services.

Key Trends and Drivers:

The Companion Animal Vaccines Market is experiencing robust growth due to increased pet ownership and heightened awareness of animal health. A significant trend is the rising demand for advanced vaccines that offer broader protection and fewer side effects. This is driven by pet owners who are more informed and proactive about their pets' health. Technological advancements in biotechnology are fostering the development of novel vaccines, enhancing efficacy and safety. These innovations are crucial as they address emerging diseases and adapt to evolving pathogens. Moreover, the trend towards personalized veterinary medicine is gaining traction, with vaccines being tailored to the specific needs of individual animals, optimizing health outcomes. Furthermore, the regulatory landscape is evolving to support faster approval processes for new vaccines, reducing time-to-market. This is especially pertinent as global concerns over zoonotic diseases rise, prompting a more agile response to potential outbreaks. Opportunities abound in emerging markets where pet adoption rates are climbing, and veterinary infrastructure is expanding. Companies that can navigate diverse regulatory environments and offer cost-effective solutions are poised to capture significant market share. The focus on preventive care and long-term health benefits ensures sustained demand for companion animal vaccines.

Restraints and Challenges:

The Companion Animal Vaccines Market is currently encountering several significant restraints and challenges. A prominent challenge is the high cost associated with vaccine development and production, which limits accessibility for smaller veterinary practices and pet owners. Regulatory hurdles also pose a significant barrier, as the approval process for new vaccines can be lengthy and costly, delaying market entry. Additionally, there is a growing concern about vaccine hesitancy among pet owners, fueled by misinformation and skepticism about vaccine safety and efficacy. This hesitancy can lead to lower vaccination rates and increased vulnerability to disease outbreaks. Furthermore, the market is constrained by the limited shelf life and storage requirements of vaccines, which complicate distribution logistics and increase costs. Lastly, the emergence of new and evolving pathogens requires continuous research and development, straining resources and challenging manufacturers to keep pace with the dynamic landscape. These challenges collectively hinder the growth and expansion of the Companion Animal Vaccines Market.

Key Players:

Boehringer Ingelheim Animal Health, Elanco Animal Health, Virbac, Ceva Sante Animale, Vetoquinol, Heska Corporation, IDEXX Laboratories, Zoetis, Phibro Animal Health, Neogen Corporation, Biogenesis Bago, Hipra, Bioveta, Merial, MSD Animal Health, Bimeda, Aratana Therapeutics, Dechra Pharmaceuticals, Kyoritsu Seiyaku, Merial Animal Health, Arcaplanet S.p.A. has acquired Merial Italia S.p.A., so the main corporate website you're looking for has changed. You can find information about the company that acquired Merial Italia S.p.A. by visiting:

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Companion Animal Vaccines Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Companion Animal Vaccines Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Functionality
  • 2.9 Key Highlights of the Market, by Services
  • 2.10 Key Highlights of the Market, by Deployment
  • 2.11 Key Highlights of the Market, by Material Type
  • 2.12 Key Highlights of the Market, by Stage
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Functionality
  • 3.8 Market Attractiveness Analysis, by Services
  • 3.9 Market Attractiveness Analysis, by Deployment
  • 3.10 Market Attractiveness Analysis, by Material Type
  • 3.11 Market Attractiveness Analysis, by Stage
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Companion Animal Vaccines Market Outlook

  • 4.1 Companion Animal Vaccines Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Companion Animal Vaccines Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Companion Animal Vaccines Market Size

  • 6.1 Companion Animal Vaccines Market Size, by Value
  • 6.2 Companion Animal Vaccines Market Size, by Volume

7: Companion Animal Vaccines Market, by Type

  • 7.1 Market Overview
  • 7.2 Live Attenuated Vaccines
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Inactivated Vaccines
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Recombinant Vaccines
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Toxoid Vaccines
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Conjugate Vaccines
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Subunit Vaccines
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 DNA Vaccines
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Others
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region

8: Companion Animal Vaccines Market, by Product

  • 8.1 Market Overview
  • 8.2 Canine Vaccines
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Feline Vaccines
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Equine Vaccines
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: Companion Animal Vaccines Market, by Technology

  • 9.1 Market Overview
  • 9.2 Recombinant DNA Technology
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Cell Culture Technology
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Others
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region

10: Companion Animal Vaccines Market, by Application

  • 10.1 Market Overview
  • 10.2 Rabies
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Distemper
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Parvovirus
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Leptospirosis
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Feline Leukemia
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Equine Influenza
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Companion Animal Vaccines Market, by End User

  • 11.1 Market Overview
  • 11.2 Veterinary Clinics
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Animal Hospitals
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Research Institutes
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Companion Animal Vaccines Market, by Functionality

  • 12.1 Market Overview
  • 12.2 Prophylactic Vaccines
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Therapeutic Vaccines
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Others
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region

13: Companion Animal Vaccines Market, by Services

  • 13.1 Market Overview
  • 13.2 Vaccination Services
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Consultation Services
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Companion Animal Vaccines Market, by Deployment

  • 14.1 Market Overview
  • 14.2 On-premise
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Cloud-based
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Companion Animal Vaccines Market, by Material Type

  • 15.1 Market Overview
  • 15.2 Biologicals
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Synthetic
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Companion Animal Vaccines Market, by Stage

  • 16.1 Market Overview
  • 16.2 Preclinical
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Clinical Trials
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Commercialized
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Companion Animal Vaccines Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Technology
    • 17.2.5 North America Market Size and Forecast, by Application
    • 17.2.6 North America Market Size and Forecast, by End User
    • 17.2.7 North America Market Size and Forecast, by Functionality
    • 17.2.8 North America Market Size and Forecast, by Services
    • 17.2.9 North America Market Size and Forecast, by Deployment
    • 17.2.10 North America Market Size and Forecast, by Material Type
    • 17.2.11 North America Market Size and Forecast, by Stage
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Technology
      • 17.2.9.4 United States Market Size and Forecast, by Application
      • 17.2.9.5 United States Market Size and Forecast, by End User
      • 17.2.9.6 United States Market Size and Forecast, by Functionality
      • 17.2.9.7 United States Market Size and Forecast, by Services
      • 17.2.9.8 United States Market Size and Forecast, by Deployment
      • 17.2.9.9 United States Market Size and Forecast, by Material Type
      • 17.2.9.10 United States Market Size and Forecast, by Stage
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Technology
      • 17.2.10.4 Canada Market Size and Forecast, by Application
      • 17.2.10.5 Canada Market Size and Forecast, by End User
      • 17.2.10.6 Canada Market Size and Forecast, by Functionality
      • 17.2.10.7 Canada Market Size and Forecast, by Services
      • 17.2.10.8 Canada Market Size and Forecast, by Deployment
      • 17.2.10.9 Canada Market Size and Forecast, by Material Type
      • 17.2.10.10 Canada Market Size and Forecast, by Stage
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Technology
    • 17.3.5 Europe Market Size and Forecast, by Application
    • 17.3.6 Europe Market Size and Forecast, by End User
    • 17.3.7 Europe Market Size and Forecast, by Functionality
    • 17.3.8 Europe Market Size and Forecast, by Services
    • 17.3.9 Europe Market Size and Forecast, by Deployment
    • 17.3.10 Europe Market Size and Forecast, by Material Type
    • 17.3.11 Europe Market Size and Forecast, by Stage
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Material Type
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Technology
      • 17.3.10.4 Germany Market Size and Forecast, by Application
      • 17.3.10.5 Germany Market Size and Forecast, by End User
      • 17.3.10.6 Germany Market Size and Forecast, by Functionality
      • 17.3.10.7 Germany Market Size and Forecast, by Services
      • 17.3.10.8 Germany Market Size and Forecast, by Deployment
      • 17.3.10.9 Germany Market Size and Forecast, by Material Type
      • 17.3.10.10 Germany Market Size and Forecast, by Stage
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Technology
      • 17.3.11.4 France Market Size and Forecast, by Application
      • 17.3.11.5 France Market Size and Forecast, by End User
      • 17.3.11.6 France Market Size and Forecast, by Functionality
      • 17.3.11.7 France Market Size and Forecast, by Services
      • 17.3.11.8 France Market Size and Forecast, by Deployment
      • 17.3.11.9 France Market Size and Forecast, by Material Type
      • 17.3.11.10 France Market Size and Forecast, by Stage
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Technology
      • 17.3.12.4 Spain Market Size and Forecast, by Application
      • 17.3.12.5 Spain Market Size and Forecast, by End User
      • 17.3.12.6 Spain Market Size and Forecast, by Functionality
      • 17.3.12.7 Spain Market Size and Forecast, by Services
      • 17.3.12.8 Spain Market Size and Forecast, by Deployment
      • 17.3.12.9 Spain Market Size and Forecast, by Material Type
      • 17.3.12.10 Spain Market Size and Forecast, by Stage
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Technology
      • 17.3.13.4 Italy Market Size and Forecast, by Application
      • 17.3.13.5 Italy Market Size and Forecast, by End User
      • 17.3.13.6 Italy Market Size and Forecast, by Functionality
      • 17.3.13.7 Italy Market Size and Forecast, by Services
      • 17.3.13.8 Italy Market Size and Forecast, by Deployment
      • 17.3.13.9 Italy Market Size and Forecast, by Material Type
      • 17.3.13.10 Italy Market Size and Forecast, by Stage
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.4 Netherlands Market Size and Forecast, by Application
      • 17.3.14.5 Netherlands Market Size and Forecast, by End User
      • 17.3.14.6 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.7 Netherlands Market Size and Forecast, by Services
      • 17.3.14.8 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.9 Netherlands Market Size and Forecast, by Material Type
      • 17.3.14.10 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Technology
      • 17.3.15.4 Sweden Market Size and Forecast, by Application
      • 17.3.15.5 Sweden Market Size and Forecast, by End User
      • 17.3.15.6 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.7 Sweden Market Size and Forecast, by Services
      • 17.3.15.8 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.9 Sweden Market Size and Forecast, by Material Type
      • 17.3.15.10 Sweden Market Size and Forecast, by Stage
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.4 Switzerland Market Size and Forecast, by Application
      • 17.3.16.5 Switzerland Market Size and Forecast, by End User
      • 17.3.16.6 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.7 Switzerland Market Size and Forecast, by Services
      • 17.3.16.8 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.9 Switzerland Market Size and Forecast, by Material Type
      • 17.3.16.10 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Technology
      • 17.3.17.4 Denmark Market Size and Forecast, by Application
      • 17.3.17.5 Denmark Market Size and Forecast, by End User
      • 17.3.17.6 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.7 Denmark Market Size and Forecast, by Services
      • 17.3.17.8 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.9 Denmark Market Size and Forecast, by Material Type
      • 17.3.17.10 Denmark Market Size and Forecast, by Stage
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Technology
      • 17.3.18.4 Finland Market Size and Forecast, by Application
      • 17.3.18.5 Finland Market Size and Forecast, by End User
      • 17.3.18.6 Finland Market Size and Forecast, by Functionality
      • 17.3.18.7 Finland Market Size and Forecast, by Services
      • 17.3.18.8 Finland Market Size and Forecast, by Deployment
      • 17.3.18.9 Finland Market Size and Forecast, by Material Type
      • 17.3.18.10 Finland Market Size and Forecast, by Stage
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Technology
      • 17.3.19.4 Russia Market Size and Forecast, by Application
      • 17.3.19.5 Russia Market Size and Forecast, by End User
      • 17.3.19.6 Russia Market Size and Forecast, by Functionality
      • 17.3.19.7 Russia Market Size and Forecast, by Services
      • 17.3.19.8 Russia Market Size and Forecast, by Deployment
      • 17.3.19.9 Russia Market Size and Forecast, by Material Type
      • 17.3.19.10 Russia Market Size and Forecast, by Stage
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Material Type
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Material Type
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Technology
      • 17.4.9.4 China Market Size and Forecast, by Application
      • 17.4.9.5 China Market Size and Forecast, by End User
      • 17.4.9.6 China Market Size and Forecast, by Functionality
      • 17.4.9.7 China Market Size and Forecast, by Services
      • 17.4.9.8 China Market Size and Forecast, by Deployment
      • 17.4.9.9 China Market Size and Forecast, by Material Type
      • 17.4.9.10 China Market Size and Forecast, by Stage
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Technology
      • 17.4.10.4 India Market Size and Forecast, by Application
      • 17.4.10.5 India Market Size and Forecast, by End User
      • 17.4.10.6 India Market Size and Forecast, by Functionality
      • 17.4.10.7 India Market Size and Forecast, by Services
      • 17.4.10.8 India Market Size and Forecast, by Deployment
      • 17.4.10.9 India Market Size and Forecast, by Material Type
      • 17.4.10.10 India Market Size and Forecast, by Stage
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Technology
      • 17.4.11.4 Japan Market Size and Forecast, by Application
      • 17.4.11.5 Japan Market Size and Forecast, by End User
      • 17.4.11.6 Japan Market Size and Forecast, by Functionality
      • 17.4.11.7 Japan Market Size and Forecast, by Services
      • 17.4.11.8 Japan Market Size and Forecast, by Deployment
      • 17.4.11.9 Japan Market Size and Forecast, by Material Type
      • 17.4.11.10 Japan Market Size and Forecast, by Stage
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Technology
      • 17.4.12.4 South Korea Market Size and Forecast, by Application
      • 17.4.12.5 South Korea Market Size and Forecast, by End User
      • 17.4.12.6 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.7 South Korea Market Size and Forecast, by Services
      • 17.4.12.8 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.9 South Korea Market Size and Forecast, by Material Type
      • 17.4.12.10 South Korea Market Size and Forecast, by Stage
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Technology
      • 17.4.13.4 Australia Market Size and Forecast, by Application
      • 17.4.13.5 Australia Market Size and Forecast, by End User
      • 17.4.13.6 Australia Market Size and Forecast, by Functionality
      • 17.4.13.7 Australia Market Size and Forecast, by Services
      • 17.4.13.8 Australia Market Size and Forecast, by Deployment
      • 17.4.13.9 Australia Market Size and Forecast, by Material Type
      • 17.4.13.10 Australia Market Size and Forecast, by Stage
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Technology
      • 17.4.14.4 Singapore Market Size and Forecast, by Application
      • 17.4.14.5 Singapore Market Size and Forecast, by End User
      • 17.4.14.6 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.7 Singapore Market Size and Forecast, by Services
      • 17.4.14.8 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.9 Singapore Market Size and Forecast, by Material Type
      • 17.4.14.10 Singapore Market Size and Forecast, by Stage
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.4 Indonesia Market Size and Forecast, by Application
      • 17.4.15.5 Indonesia Market Size and Forecast, by End User
      • 17.4.15.6 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.7 Indonesia Market Size and Forecast, by Services
      • 17.4.15.8 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.9 Indonesia Market Size and Forecast, by Material Type
      • 17.4.15.10 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.4 Taiwan Market Size and Forecast, by Application
      • 17.4.16.5 Taiwan Market Size and Forecast, by End User
      • 17.4.16.6 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.7 Taiwan Market Size and Forecast, by Services
      • 17.4.16.8 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.9 Taiwan Market Size and Forecast, by Material Type
      • 17.4.16.10 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.4 Malaysia Market Size and Forecast, by Application
      • 17.4.17.5 Malaysia Market Size and Forecast, by End User
      • 17.4.17.6 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.7 Malaysia Market Size and Forecast, by Services
      • 17.4.17.8 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.9 Malaysia Market Size and Forecast, by Material Type
      • 17.4.17.10 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Material Type
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Technology
    • 17.5.5 Latin America Market Size and Forecast, by Application
    • 17.5.6 Latin America Market Size and Forecast, by End User
    • 17.5.7 Latin America Market Size and Forecast, by Functionality
    • 17.5.8 Latin America Market Size and Forecast, by Services
    • 17.5.9 Latin America Market Size and Forecast, by Deployment
    • 17.5.10 Latin America Market Size and Forecast, by Material Type
    • 17.5.11 Latin America Market Size and Forecast, by Stage
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Technology
      • 17.5.9.4 Brazil Market Size and Forecast, by Application
      • 17.5.9.5 Brazil Market Size and Forecast, by End User
      • 17.5.9.6 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.7 Brazil Market Size and Forecast, by Services
      • 17.5.9.8 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.9 Brazil Market Size and Forecast, by Material Type
      • 17.5.9.10 Brazil Market Size and Forecast, by Stage
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Technology
      • 17.5.10.4 Mexico Market Size and Forecast, by Application
      • 17.5.10.5 Mexico Market Size and Forecast, by End User
      • 17.5.10.6 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.7 Mexico Market Size and Forecast, by Services
      • 17.5.10.8 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.9 Mexico Market Size and Forecast, by Material Type
      • 17.5.10.10 Mexico Market Size and Forecast, by Stage
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Technology
      • 17.5.11.4 Argentina Market Size and Forecast, by Application
      • 17.5.11.5 Argentina Market Size and Forecast, by End User
      • 17.5.11.6 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.7 Argentina Market Size and Forecast, by Services
      • 17.5.11.8 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.9 Argentina Market Size and Forecast, by Material Type
      • 17.5.11.10 Argentina Market Size and Forecast, by Stage
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Material Type
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Material Type
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Material Type
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Technology
      • 17.6.10.4 UAE Market Size and Forecast, by Application
      • 17.6.10.5 UAE Market Size and Forecast, by End User
      • 17.6.10.6 UAE Market Size and Forecast, by Functionality
      • 17.6.10.7 UAE Market Size and Forecast, by Services
      • 17.6.10.8 UAE Market Size and Forecast, by Deployment
      • 17.6.10.9 UAE Market Size and Forecast, by Material Type
      • 17.6.10.10 UAE Market Size and Forecast, by Stage
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Technology
      • 17.6.11.4 South Africa Market Size and Forecast, by Application
      • 17.6.11.5 South Africa Market Size and Forecast, by End User
      • 17.6.11.6 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.7 South Africa Market Size and Forecast, by Services
      • 17.6.11.8 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.9 South Africa Market Size and Forecast, by Material Type
      • 17.6.11.10 South Africa Market Size and Forecast, by Stage
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Material Type
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Boehringer Ingelheim Animal Health
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Elanco Animal Health
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Virbac
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Ceva Sante Animale
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Vetoquinol
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Heska Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 IDEXX Laboratories
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Zoetis
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Phibro Animal Health
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Neogen Corporation
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Biogenesis Bago
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Hipra
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Bioveta
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Merial
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 MSD Animal Health
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Bimeda
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Aratana Therapeutics
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Dechra Pharmaceuticals
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Kyoritsu Seiyaku
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Merial Animal Health
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제